Why Both Wegovy and Mounjaro Are Available Here
What's Best Mounjaro or Wegovy: Understanding the Core Differences
When patients ask "what's best Mounjaro or Wegovy," the fundamental distinction lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, a dual agonist that targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, potentially offering enhanced metabolic effects through this broader hormonal pathway.
Both prescription-only medicines require careful dose escalation and ongoing medical supervision. Wegovy follows a 5-dose escalation from 0.25mg to 2.4mg over 16 weeks, whilst Mounjaro uses 6 doses ranging from 2.5mg to 15mg with different timing intervals. Your prescriber will consider factors including your medical history, current medications, tolerance to gastrointestinal side effects, and individual response patterns when determining what's best Mounjaro or Wegovy for your circumstances.
Wegovy vs Mounjaro: Transparent Pricing and Value Comparison
EverydayMeds offers competitive pricing for both treatments, allowing direct cost comparison when deciding what's best Mounjaro or Wegovy. Wegovy single pens start from £79.99 (0.25mg starter dose) progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg) to £209.99 (2.4mg maintenance dose), with new customers receiving FIRST40 discount applied at checkout. Our Wegovy bundles include the Intro Duo (0.25mg & 0.5mg) for £169.99 and Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99, providing convenient multi-month supplies.
Mounjaro pricing follows a different structure reflecting its distinct dosing schedule and manufacturing costs. Rather than focusing purely on cost when considering what's best Mounjaro or Wegovy, patients should evaluate the total value including storage convenience, dosing frequency, and individual tolerability profiles. Our clinical team at GPhC #9012878 provides detailed cost-benefit analysis during consultations, ensuring you understand the financial commitment for either treatment path.
Clinical Evidence: What's Best Mounjaro or Wegovy Based on Trial Data
Wegovy's efficacy is demonstrated through the STEP clinical trial programme, with STEP 1 showing patients achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
Mounjaro's SURMOUNT trials have shown promising results, though direct head-to-head comparisons between the treatments use different trial designs, patient populations, and endpoints, making direct percentage comparisons inappropriate. When evaluating what's best Mounjaro or Wegovy based on clinical evidence, patients should focus on the consistency of results, safety profiles, and how trial participants' characteristics align with their own health status rather than comparing headline weight loss figures.
How Wegovy Works for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone GLP-1 that your intestines release after eating. This mechanism reduces appetite by slowing gastric emptying, meaning food stays in your stomach longer, creating sustained feelings of fullness. The medication also acts on appetite centres in your brain, potentially reducing food cravings and the psychological drive to eat. Additionally, Wegovy may improve insulin sensitivity and glucose metabolism, supporting overall metabolic health. When administered once weekly via the convenient FlexTouch pen, Wegovy provides consistent therapeutic levels throughout the week. However, its effectiveness depends on concurrent lifestyle modifications including a reduced-calorie diet and increased physical activity, as the medication enhances rather than replaces healthy weight management behaviours.
EverydayMeds Ordering Process: From Assessment to Delivery
Our streamlined process begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any previous experience with GLP-1 treatments. Your responses undergo review by our qualified prescribers within 3 working days (express 24-hour service available), who evaluate your suitability for either Wegovy or Mounjaro based on MHRA licensing criteria and clinical guidelines. Once approved, your prescription-only medicine is prepared in our GPhC-registered pharmacy and dispatched via next-day delivery using temperature-controlled cold-chain logistics. All medications arrive in discrete, insulated packaging maintaining the required 2-8°C storage temperature from our pharmacy to your door. Our clinical team remains available throughout your treatment journey for dose adjustment guidance, side effect management, and ongoing support, ensuring optimal outcomes regardless of whether Wegovy or Mounjaro proves most suitable for your needs.
Storage and Practical Considerations: Wegovy vs Mounjaro
Storage requirements present a practical advantage when considering what's best Mounjaro or Wegovy for your lifestyle. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, offering superior flexibility for travel, work schedules, or situations where refrigeration access is limited. Mounjaro pens maintain stability for 21 days at room temperature, still convenient but requiring more careful planning for extended periods away from home. Both treatments require initial refrigerated storage at 2-8°C and should be protected from light and freezing temperatures. The FlexTouch pen system used for Wegovy delivery provides precise dose administration with clear dosage windows and ergonomic design. Dose escalation with Wegovy follows a structured 4-week schedule for each increase, allowing your body to gradually adjust and minimising gastrointestinal side effects, whilst Mounjaro uses variable escalation timing based on individual tolerance and response.
Dual Agonist vs Single Agonist: What's Best Mounjaro or Wegovy Mechanism
The mechanistic difference between Wegovy's single GLP-1 targeting and Mounjaro's dual GIP/GLP-1 approach represents a fundamental consideration in determining what's best Mounjaro or Wegovy for individual patients. Mounjaro's dual agonist activity may provide enhanced metabolic effects through GIP receptor activation, which influences insulin secretion, fat metabolism, and potentially brown adipose tissue activity. This broader hormonal pathway could theoretically offer advantages for patients with specific metabolic profiles or those who haven't achieved optimal results with single GLP-1 agonists.
However, Wegovy's targeted GLP-1 mechanism provides well-established efficacy with extensive real-world safety data accumulated over several years of clinical use. Some patients may prefer the simplicity and predictability of single-pathway targeting, particularly those sensitive to gastrointestinal effects or managing multiple medications. Your prescriber can help evaluate whether the theoretical benefits of dual agonist activity outweigh the proven track record of GLP-1-focused treatment when determining what's best Mounjaro or Wegovy for your specific circumstances.
Start Your Weight Management Journey: Choose Wegovy or Mounjaro
Both Wegovy and Mounjaro represent evidence-based approaches to weight management, each offering distinct advantages depending on your individual needs, preferences, and medical profile. Rather than declaring what's best Mounjaro or Wegovy universally, our clinical approach focuses on matching treatment characteristics to patient requirements through careful assessment and ongoing monitoring. New customers can access either treatment using discount code FIRST40 applied at checkout, while returning patients benefit from DOSE25 savings on subsequent orders. Our GPhC #9012878 registered pharmacy ensures authentic medications, expert clinical oversight, and comprehensive support throughout your weight management journey. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover which treatment aligns with your goals. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which option provides the optimal balance of efficacy, convenience, and tolerability for your unique circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
